These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24613521)

  • 1. Irregular tick-borne encephalitis vaccination schedules: the effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study.
    Schosser R; Reichert A; Mansmann U; Unger B; Heininger U; Kaiser R
    Vaccine; 2014 Apr; 32(20):2375-81. PubMed ID: 24613521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules.
    Wittermann C; Schöndorf I; Gniel D
    Vaccine; 2009 Mar; 27(10):1661-6. PubMed ID: 18940221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
    Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5mL in adults.
    Konior R; Brzostek J; Poellabauer EM; Jiang Q; Harper L; Erber W
    Vaccine; 2017 Jun; 35(28):3607-3613. PubMed ID: 28545923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly--results from an observational study.
    Jílková E; Vejvalková P; Stiborová I; Skorkovský J; Král V
    Expert Opin Biol Ther; 2009 Jul; 9(7):797-803. PubMed ID: 19527104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.
    Prymula R; Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Angermayr R; Geisberger A; Barrett PN; Ehrlich HJ
    Hum Vaccin Immunother; 2012 Jun; 8(6):736-42. PubMed ID: 22699436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Firth C; Petermann R; Barrett PN; Ehrlich HJ
    Vaccine; 2011 Oct; 29(43):7307-19. PubMed ID: 21843576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur Children.
    Wittermann C; Petri E; Zent O
    Vaccine; 2009 Mar; 27(10):1585-8. PubMed ID: 19162115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the booster interval for the tick-borne encephalitis (TBE) vaccine 'FSME-IMMUN' be prolonged? - A systematic review.
    Steffen R; Erber W; Schmitt HJ
    Ticks Tick Borne Dis; 2021 Sep; 12(5):101779. PubMed ID: 34298356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.
    Loew-Baselli A; Konior R; Pavlova BG; Fritsch S; Poellabauer E; Maritsch F; Harmacek P; Krammer M; Barrett PN; Ehrlich HJ;
    Vaccine; 2006 Jun; 24(24):5256-63. PubMed ID: 16624457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.
    Plentz A; Jilg W; Schwarz TF; Kuhr HB; Zent O
    Vaccine; 2009 Feb; 27(6):853-6. PubMed ID: 19071180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against tick-borne encephalitis--distant evaluation.
    Bobrowska E; Grzeszczuk A; Prokopowicz D
    Rocz Akad Med Bialymst; 1996; 41(1):44-50. PubMed ID: 8673804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety.
    Beran J; Xie F; Zent O
    Vaccine; 2014 Jul; 32(34):4275-80. PubMed ID: 24950352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults.
    Poellabauer E; Angermayr R; Behre U; Zhang P; Harper L; Schmitt HJ; Erber W
    Vaccine; 2019 May; 37(24):3241-3250. PubMed ID: 30928173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of immunity to tick-borne encephalitis after vaccination and natural infection.
    Baldovin T; Mel R; Bertoncello C; Carpenè G; Soppelsa F; Giliberti A; Baldo V
    J Med Virol; 2012 Aug; 84(8):1274-8. PubMed ID: 22711356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of antibodies after vaccination against tick-borne encephalitis.
    Rendi-Wagner P; Zent O; Jilg W; Plentz A; Beran J; Kollaritsch H
    Int J Med Microbiol; 2006 May; 296 Suppl 40():202-7. PubMed ID: 16524776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Koska M; Bobrovsky R; Konior R; Ehrlich HJ
    Hum Vaccin; 2009 Aug; 5(8):551-6. PubMed ID: 19430202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.
    Kantele A; Rombo L; Vene S; Kundi M; Lindquist L; Erra EO
    Vaccine; 2022 Feb; 40(9):1299-1305. PubMed ID: 35101266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of protective immunity following vaccination against tick-borne encephalitis--longer than expected?
    Rendi-Wagner P; Kundi M; Zent O; Dvorak G; Jaehnig P; Holzmann H; Mikolasek A; Kollaritsch H
    Vaccine; 2004 Jul; 22(21-22):2743-9. PubMed ID: 15246606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence.
    Beran J; Lattanzi M; Xie F; Moraschini L; Galgani I
    Vaccine; 2019 Jul; 37(32):4623-4629. PubMed ID: 29397225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.